Pharmaceutical Channel

How Ozmosi is helping transform how the world gets its medicine

 
 
Beau Bush, President and Founder of Ozmosi, discusses the trends shaping the Pharma Analytics industry and what Ozmosi is doing to help transform this field joins eHealth Radio and the Health Care, Health News and Pharmaceutical Channels.
Listen to interview with host Eric Michaels and guest Beau Bush discuss the following:
What is Ozmosi? What were the elements that stimulated the conception for the company? Can you give us a quick snapshot of the company’s history and its evolution over the years?
What exactly does your company help them to do?  What kind of challenges do they face?
Could you give some insight on the current technological trends shaping the Pharma Analytics industry? Also, how do you inject those trends into the effective solutions you offer?
Can you talk more about the free website you mentioned?  How does that play a role in all of this?
Ozmosi invests greatly on innovative technologies to enhance Pharma Analytics measures. Can you please elaborate on the technologies you follow and the way you implement them within your client’s operations?
What do you hope the industry can accomplish with advances in technology? Who would benefit most from your solutions services?
Talking about the pharmaceutical industry’s roadmap, where do you see things in a few years down the lane? And how will this ultimately change the healthcare industry as we know it?
 
Beau Bush is the President and Founder of Ozmosi. Beau brings to every client a rich background in predictive analytics, risk assessments, and valuation models for the pharmaceutical industry. He has more than 15 years of experience in developing data-based business and investment strategies, including extensive experience preparing and delivering senior-level summaries and recommendations for global investment and growth strategies.
After more than a decade working on new product development, Beau left his position as Associate Director of Strategy and Portfolio Analysis at Janssen (Johnson & Johnson) in 2013, when he saw the opportunity to engage more directly with an increasingly complex and dynamic healthcare market.
With newly emerging business models and increasing complexity in drug development making it more and more difficult to predict the impact of new products—or decide which products to pursue—Beau envisioned a company that could bring clarity and confidence to the investment decisions that shape tomorrow’s pharmaceutical products. In 2012 he launched Ozmosi, a competitive pharmaceutical analytics company based in New Jersey.
Beau has a BS in biology from Rutgers University and has worked in several industries, including finance, pharmaceuticals, marine biology, environmental science, and business consulting.  He brings to Ozmosi a deep understanding and broad knowledge of global market valuation and healthcare product development, as well as an extensive network of industry experts.
 
Websites: GlobalClinicalTrialData.com | www.ozmosi.com

New Survey Finds the Majority of Consumers Are Unaware of the Risks Associated with Buying Prescription Drugs Online and Oppose Legalizing Importation from Canada

 
 
Libby Baney, Executive Director of the Alliance for Safe Online Pharmacies, a non-profit organization dedicated to making the Internet safe for consumers worldwide again joins eHealth Radio and the Pharmaceutical & Health News Channels.
 
Listen to interview with host Eric Michaels and guest Libby Baney discuss the following:
What made ASOP Global decide to do this poll right now?
What were some of the GENERAL findings from the new asop global survey?
What's the danger in just searching for your medicine and ordering online?
What are the risks associated with buying prescription drugs from illegal online pharmacies?
Congress is considering legislation that would legalize the importation of prescription medicines from Canada. How do consumers feel about this issue?
What were the top factors that changed their minds?
What can people do to STAY SAFE OR SAVE MONEY when shopping for medicines online?
 
Libby Baney is the executive director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C. which she founded in 2009. In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers.
A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.
Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.
In addition to her work for ASOP, Libby is a partner at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.
 
Website: www.BuySafeRx.pharmacy
Facebook: https://www.facebook.com/BuySafeRx
 

The shadowy world of sports supplements

 
Robert Tauler, managing partner at Tauler Smith, a Los Angeles attorney who protects the nutritional supplement market from people who openly sell illegal steroids and amphetamines as sports supplements joins eHealth Radio and the Health News, Legal & Supplement Channels.
 
Listen to interview with host Eric Michaels & guest Robert Tauler discuss the following:
Tell us a bit about problem of illegal steroids being sold right out in the open online and in sports nutrition stores. How big is the problem and what’s at stake?
How do these companies work and why can they operate so openly? Where’s the FDA in policing this problem?
What are the most common kinds of illegal supplements being sold right now, how do they work, and what are the risks and known side-effects? Do you know of any cases of someone suffering serious physical injury from illegal supplements that you can share with us?
How do you use the law to go after these bad actors? How effective have you been in getting the courts to force these people to take these poisons off the market?
Who is the market these people sell to? Can you tell us something about the buyers and the sellers? Who makes these supplements? Do the makers of these supplements have any medical backgrounds or qualifications that lets them experiment on customers with unapproved pharmaceutical research drugs?
How can unsuspecting people protect themselves from these substances? What should they know? How should they read a supplement’s label?
 
Los Angeles trial attorney Robert Tauler devotes the majority of his practice to nutritional supplement litigation, specifically eliminating steroid and amphetamine analogs from over-the-counter sports supplements. These drugs are sold openly in stores and online under all sorts of names with no warnings about side effects, whether the chemicals have been banned for human consumption, or whether they are outright illegal — as all steroids are without a doctor’s prescription.In 2016, he was  awarded "Attorney of the Year" by the Los Angeles Westside Bar Association. In 2015 he obtained a $10 million jury verdict against a supplement manufacturer, which was among the top 25 highest verdicts in California that year.Tauler, a native Californian, is a 2005 graduate from Harvard Law School. He was honored as an NCAA Big West Scholar-Athlete while an undergraduate at the University of California, Irvine, where he majored in political science and played on the Anteater’s nationally-ranked men’s volleyball team.
 
 
Website: taulersmith.com

Importing Prescription Drugs from Other Countries, Including Canada, Puts U.S. Consumers at Risk

 
Libby Baney, Principal at Faegre Baker Daniels Consulting and Executive Director of the Alliance for Safe Online Pharmacies, a non-profit organization dedicated to making the Internet safe for consumers worldwide again joins eHealth Radio and the Pharmaceutical & Health News Channels. ASOP Global recently launched a campaign to educate policymakers, consumers and others about the dangers of buying prescription drugs from other countries, including Canada.
 
Listen to interview with host Eric Michaels and guest Libby Baney discuss the following:
How prevalent are illegal online pharmacies?
There’s been a lot of discussion about legalizing the importation of prescription drugs from Canada. What Do U.S. Residents Get When They Search for a “Canadian Online Pharmacy”?
Are There ANY Legitimate Canadian Online Pharmacies?
Why Can’t Congress Just Make It Legal for U.S. Residents to Buy From Only Websites Supplying from Actual Canadian Pharmacies?
Doesn't this new importation bill have built-in safeguards?
Can the U.S. Increase U.S. Government Enforcement Authority and Penalties for Illegal Actors?
What Are the Risks to U.S. Residents Who Buy From a “Canadian” Online Pharmacy?
What can consumers do to stay safe when shopping for medicines online?
 
Libby Baney is the executive director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C. which she founded in 2009. In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers.
A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.
Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.
In addition to her work for ASOP, Libby is a partner at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.
 
Website: www.BuySafeRx.pharmacy
Facebook: https://www.facebook.com/BuySafeRx

Building a Better Fat Trap. Q & A with Gary Thompson, M Pharmaceuticals

Gary Thompson, President and CEO of M Pharmaceuticals USA, a clinical-stage company developing innovative technologies for obesity and weight management joins eHealth Radio and the Health News, Pharmaceutical & Weight Management Channels.
 
Listen to interview with host Eric Michaels and guest Gary Thompson discuss the following:
A fat loss drug is the holy grail, what has been the challenges in developing a drug that actually works?
With drugs that "trap fat", what have been the issues surrounding Orlistat products currently on the market?
Your company has redesigned this drug, now called C-103, to address "bathroom issues", how does this new drug work?
What have studies for C-103 demonstrated so far?
Would your drug work against other illnesses that affect the obese such as fatty liver disease, if so, how?
What is the next step for your diet drug?
 
Gary A. Thompson, B.S. is President & CEO M-Pharmaceutical U.S.A. Inc. Thomspon has 30 years plus of sales and management experience in Fortune 500 health care organizations and start up pharmaceutical companies. He has served as Vice President of sales for Cigna Healthcare managing billions of assets over his career. Mr. Thompson's management and leadership roles with start up ventures including ToConceive LLC., (510K FDA Clearance ) in women's health and wellness, and in the obesity space as President of M-Pharma's newly acquired Chelatexx, LLC., C-103 reformulated orlistat.
 
Website: www.m-pharma.ca
Social Media Links: Facebook: facebook.com/pages/M-Pharmaceutical-Inc Twitter: @MPharmaceutical

Healthcare Providers Have a Vital Role to Play in Educating Patients About Illegal Online Pharmacies

Libby Baney, Executive Director of the Alliance for Safe Online Pharmacies, a non-profit organization dedicated to making the Internet safe for consumers worldwide again joins eHealth Radio and the Pharmaceutical & Health News Channels.
ASOP Global recently launched a campaign to educate pharmacists, doctors and other healthcare providers about illegal online pharmacies, counterfeit medicines and the tools they need to help keep their patients safe online.
Listen to interview with host Eric Michaels and guest Libby Baney discuss the following:
What is the Alliance for Safe Online Pharmacies?
Why is the focus of your new campaign healthcare providers?
How prevalent are illegal online pharmacies?
What are the risks associated with buying prescription drugs from illegal online pharmacies?
Can you tell our listeners what to look out for to avoid these dangers?
Summary: What can consumers do to stay safe when shopping for medicines online? Consumers should visit www.BuySafeRx.pharmacy to verify whether a website is safe BEFORE they order any prescription medicines online. We also encourage consumers to look for websites that end in dot-pharmacy, like www.medlife.pharmacy and www.safe.pharmacy, because only entities that are approved by NABP legally qualify to have a dot-pharmacy website. 
Libby Baney is the executive director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C. which she founded in 2009. In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers.
A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.
Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.
In addition to her work for ASOP, Libby is a partner at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.
Website: www.BuySafeRx.pharmacy
Social Media Links: Facebook: facebook.com/BuySafeRx Twitter: @BuySafeRx

Certified Geriatric Pharmacist Credential Moving to the Board of Pharmacy Specialties

William Ellis, Executive Director of the Board of Pharmacy Specialties® in Washington, D.C. joins eHealth Radio and the Health Care and Health News Channels. BPS, which is celebrating its 40th anniversary this year, is the premier post-licensure certification organization serving the pharmacy profession.
Listen to interview with host Eric Michaels and guest William Ellis discuss the following:
What is the Board of Pharmacy Specialties?
How many pharmacists are currently BPS board certified?
What sets BPS board certified pharmacists apart from other pharmacists?
What role does the BPS board certified pharmacist play as an integral member of the healthcare team?
BPS recently announced that pharmacists board certified by the Commission for Certification in Geriatric Pharmacy will now be BPS Board Certified Geriatric Pharmacists. Can you tell us about the implications of this news?
Duration: 8:52
William M. Ellis is the Executive Director for the Board of Pharmacy Specialties® (BPS), an autonomous division of the American Pharmacists Association (APhA), in Washington, D.C.  From 1997-2011, he served as CEO and Executive Director of the American Pharmacists Association (APhA) Foundation.  Ellis was the Executive Vice President for the Pennsylvania Society of Health-Systems Pharmacists from 1986-1997. Ellis also serves as Chair of the Council on Credentialing in Pharmacy which provides leadership, guidance, public information, and coordination for the profession of pharmacy's credentialing programs. In 2014, he was appointed a commissioner to the National Commission for Certifying Agencies. After receiving his pharmacy degree from the Philadelphia College of Pharmacy (PCP), Ellis completed an executive residency with the American Society of Health-System Pharmacists in 1986 and earned his Master of Science degree in health education from Saint Joseph’s University in Philadelphia in 1994. Currently he also is serving as the chair of the Philadelphia College of Pharmacy’s Board of Visitors.
Website: www.bpsweb.org
Social Media Links: Facebook: https://www.facebook.com/BoardofPharmacySpecialtiesTwitter: @BPSweb

Medication errors: The deadly problem no one is talking about

Dr. Raj Gopalan, MD, MSIS, Vice President of Innovation & Clinical Informatics at Wolters Kluwer Clinical Drug Information (CDI) joins eHealth Radio and Health Care and Pharmaceutical Channels to discuss medication errors, the deadly problem no one is talking about.
Listen to interview with host Eric Michaels & guest Dr. Raj Gopalan discuss the following: he BMJ recently reported that medical errors have become the third leading cause of death in the U.S., and other reports note that the U.S. experiences some 124,000 deaths a year specifically due to medication errors. In your experience trying to improve medication safety, what are some examples of the types of medication errors you’ve encountered?What has changed over the years to make this more of a pressing issue?How can clinicians reduce these errors and what kind of solutions are currently available to help them?What are the next steps for the healthcare community? What developments need to be made to further and more effectively pursue the reduction of medication errors?You mentioned that Wolters Kluwer Clinical Drug Information is working on advancements to help address the issue of medication errors. What are some of those advancements, and how will they play a role in helping reduce medication errors?
Duration: 13:15
Raj Gopalan, MD, MSIS, is the Vice President of Innovation & Clinical Informatics at Wolters Kluwer Clinical Drug Information (CDI), focused on developing next-generation of health information technology and clinical decision support innovations to help enable healthcare organizations to deliver precision care to patients with utmost efficiency.
Prior to joining Wolters Kluwer, Dr. Gopalan has served as a Clinical Architect and Medical Director of a large academic medical center, and as a CMIO of a large multihospital integrated delivery networks. He has also worked as a Clinical Architect for technology companies. In previous roles, he has designed, developed and implemented EMR systems across multiple community and urban hospitals.

Website: www.wolterskluwercdi.com
Follow Wolters Kluwer Clinical Drug Information:
Facebook: facebook.com/WoltersKluwerClinicalDrugInformation
Twitter: @WKDrugInfo
LinkedIn: linkedin.com/company/wolters-kluwer-clinical-drug-information

Keeping Seniors Safe from Illegal Online Pharmacies and Counterfeit Medicines

Libby Baney, Executive Director of the Alliance for Safe Online Pharmacies, an international non-profit organization dedicated to protecting the safety of consumers online again joins eHealth Radio and the Pharmaceutical & Health News Channels.
Listen to interview with host Eric Michaels & guest Libby Baney discuss the following: What is the Alliance for Safe Online Pharmacies? 
Why is the focus of your new campaign seniors and their caregivers?Can you give us some examples of what kinds of costs seniors are looking at?How prevalent are illegal online pharmacies?What are the risks associated with buying prescription drugs from illegal online pharmacies?How do people stay safe when shopping for medicines online?Earlier you mentioned to verify, if one is buying from a secure website to look to the right of the dot, what kind of protocol does a seller have to go through to own one of these kinds of websites for example a cvs.pharmacy?
Duration: 9:56
Libby Baney is the Founder and Executive Director of the Alliance for Safe Online Pharmacies (ASOP Global), an international non-profit organization based in Washington, D.C.  In this capacity, Libby leads ASOP operations, shapes public policy, and advocates for increased international attention to the issue of illegal online drug sellers. Libby began working on Internet pharmacy issues in 2009 when she helped to launch a loose coalition, which grew into ASOP Global.
A lawyer by training and health advocate by nature, Libby is a prolific speaker and writer, regularly engaging with diverse audiences on issues at the intersection of Internet technology and healthcare. She leads strategic workshops and speaks on these issues worldwide; writes policy documents; and interacts with international corporate leaders and policymakers.
Libby’s work spans multiple continents, which has been covered by local, national and international media outlets including The Wall Street Journal, The Washington Post, Politico, Roll Call, The Hill, The Los Angeles Times, USA Today, The Washington Times, The Indianapolis Star, Inside Health Policy, Pharmacy Today, ABC News, CNN, and C-SPAN.
In addition to her work for ASOP, Libby is a Senior Director at FaegreBD Consulting and Counsel with Faegre Baker Daniels LLP where she works on Internet policy, intellectual property rights, pharmacy, telemedicine/telehealth, and pharmaceutical supply chain matters.

Websites: www.safeonlinerx.com | www.XtheRisk.pharmacy
Follow on Twitter: @safeonlinerx

Growing Problem on Antibiotic Resistance, but There’s Also Reason for Hope

Dr. Ron Najafi, CEO of Emery Pharma Services joins eHealth Radio and the Health News and Pharmaceutical Channels to discuss the alarming concerns about super bugs such as Methicillin Resistance Staphylococcus Aureus (MRSA) and how it’s affecting our global health.
Listen to interview with host Eric Michaels & guest Dr. Ron Najafi discuss the following: How has antibiotic resistance become a growing worldwide public health crisis? Who is to blame for this problem?What are Staphylococcus aureus infections and how are they easily acquired in places like hospitals -- which are meant to keep us healthy?Why are researchers having a hard time replacing the existing arsenal of effective antimicrobial agents?Your company works with companies addressing this problem, what new breakthroughs do you find promising? What can we be doing as patients to also curb the problem? What safeguards can we take?
Duration: 17:21
After earning a B.S. and M.S. in chemistry at the University of San Francisco, Ron Najafi received his Ph.D. at University of California at Davis. He worked at Sigma-Aldrich, Rhone Poulenc Rorer (now Sanofi), and PerkinElmer-Applied Biosystems before leaving to found CP Lab Safety and NovaBay Pharmaceuticals.  Dr. Najafi is an innate innovator. With more than 50 patents & pending patent applications, including a class of non-antibiotic, antimicrobial compounds named Aganocides®. The leading molecule of this aganocide family of compounds, auriclosene, has a broad spectrum of antimicrobial activity against bacteria, viruses and fungi.
Ron Najafi championed development of NeutroPhase for wound care. In September 2013, working together with John Crew, MD (vascular surgeon) they developed Crew-NovaBay minimally invasive surgical procedure to treat flesh eating bacteria. NeutroPhase has been successfully used in over 40 cases diagnosed as flesh eating infection. NeutroPhase has shown in a number of critical scientific publications to neutralize the key toxins responsible for the flesh eating disease. In 2014, Ron Najafi and her sister, Kathryn (Katy) Najafi, MD (Ophthalmologist & Surgeon) discovered a unique formulation of NeutroPhase to help manage patients suffering from Blepharitis. This unique formulation was initially called i-Lid Cleanser and later changed name to AVENOVA.

Website: www.emerypharmaservices.com
Social Media Links:
Facebook: www.facebook.com/pages/Emeryville-Pharmaceutical-Services
Twitter: @EmeryvillePharm
Are you enjoying the podcast? Please, leave a review.